New Alzheimer's drug Aducanumab - cost, side effects, timeline and other questions answered

Patients and their families are starting to inquire about the new Alzheimer's drug approved this week by the US Food and Drug Administration.

About Crazy-hacker

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments:

Post a Comment